WHO says Sanofi's Dengvaxia should be used only after a dengue test—but a test doesn't yet exist

As a vaccine safety controversy continues to play out in the Philippines, WHO advisers have updated their recommendations for Sanofi's Dengvaxia. The experts said it should be administered after a test confirms recipients have had a prior infection.